• Profile
Close

The efficacy of elobixibat as bowel preparation agent for colonoscopy: A prospective, randomized, multi‐center study

Digestive Endoscopy May 14, 2021

Yamaguchi D, Hidaka H, Matsunaga T, et al. - Researchers conducted this multi‐center, randomized, observer‐blinded, non‐inferiority study to compare the effectiveness, tolerability, and safety of the combination of elobixibat and 1 L of polyethylene glycol formulation containing ascorbic acid (PEG‐Asc) solution vs the combination of sodium picosulfate and 1‐L PEG‐Asc solution as bowel preparation for colonoscopy. The sample consisted of 210 outpatients who were randomly assigned to one of two groups: elobixibat plus 1‐L PEG‐Asc group (group A) or sodium picosulfate plus 1‐L PEG‐Asc group (group B). Finally, data from 196 patients (99 in group A and 97 in group B) were analyzed. The bowel preparation time in group A was comparable to that in group B, but sleep disturbance was significantly less common in group A than in group B. Because of the equivalent bowel cleansing effect and less frequent sleep disruption, the combination of elobixibat and 1‐L PEG‐Asc can be considered an alternative bowel preparation for colonoscopy.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay